China Life commits up to 4.5 billion yuan to AI and semiconductor fund
China Life Insurance Company announced on September 24 it will invest up to 4.5 billion yuan as a limited partner in the Qingdao Chengxin Zhida Equity Investment Center, a partnership with total capital of up to 6 billion yuan. The fund will focus on unlisted equity in China's artificial intelligence and semiconductor sectors, aligning with national strategic priorities. The transaction is a related party transaction involving China Life subsidiaries.
Editorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page reads the event directly, while its address stays stable when the title changes.
- Summary covers the current reports
Cross-source coverage
Reporting timeline
China Life to Invest Up to 4.5 Billion Yuan in AI and Semiconductor Fund
China Life Insurance Company announced on September 24 that it will establish a partnership fund, Qingdao Chengxin Zhida Equity Investment Center, with a total planned capital contribution of up to 6 billion yuan. China Life will contribute up to 4.5 billion yuan as a limited partner. The fund will focus on investing in high-quality unlisted equity in China's artificial intelligence and semiconductor sectors, aligning with national strategic priorities. The partnership includes China Life's subsidiaries as general and limited partners, and other independent third-party investors. The transaction constitutes a related party transaction but does not require shareholder approval or constitute a major asset restructuring. China Life stated the investment supports its 15th Five-Year Plan, fosters new productive forces, and aims to optimize asset allocation while capturing long-term growth in hard technology. The fund manager, China Life Equity Investment, has a track record in technology investments.
Read sourceChina Life to Invest Up to 4.5 Billion Yuan in AI and Semiconductor Fund
China Life Insurance Company (601628) announced on September 24 that it will participate in establishing a new private equity fund, Qingdao Chengxin Zhida Equity Investment Center (Limited Partnership), with a total planned capital contribution of up to 6 billion yuan. China Life will contribute up to 4.5 billion yuan as a limited partner. The fund will focus on investing in high-quality unlisted equity in the artificial intelligence and semiconductor sectors, aligning with China's national strategic direction. The partnership includes China Life's subsidiaries, Guoshou Chengda and Guoshou Wuxi Fund, making the transaction a related party transaction. China Life stated the investment is part of its '15th Five-Year Plan' deployment to support emerging industries and optimize its asset allocation by capturing long-term growth in hard technology. The fund's manager, Guoshou Equity, has a track record in technology investments.
Read sourceChina Life Plans Up to 4.5 Billion Yuan Fund for AI and Semiconductor Investments
On September 24, China Life Insurance Company announced a plan to establish a new equity investment fund, Qingdao Chengxin Zhida Equity Investment Center, with total committed capital of up to 6 billion yuan. China Life will contribute up to 4.5 billion yuan. The fund will focus on investing in high-quality unlisted companies in the artificial intelligence and semiconductor sectors, aligning with China's national strategy for technological self-reliance and industrial autonomy. This is China Life's fourth announced equity investment in 'new quality productive forces' this year, bringing its total disclosed commitments to approximately 16 billion yuan. The company's Chief Investment Officer, Liu Hui, stated that China Life will continue to increase investments in core tracks such as AI, semiconductors, and green energy, viewing new quality productive forces as a key growth area for differentiated returns. The fund has a six-year term and will be managed by a China Life affiliate.
Read sourceShow 4 older updatesHide older updates
China Life Plans to Invest Up to 4.5 Billion Yuan in AI and Semiconductor Fund
China Life Insurance Company (601628.SH) announced a plan to establish a new equity investment partnership, Qingdao Chengxin Zhida Equity Investment Center (Limited Partnership), with its affiliate Guoshou Chengda (Shanghai) Health Medical Equity Investment Management Co., Ltd. and other investors. The total proposed capital contribution from all partners is up to 6 billion yuan, with China Life committing up to 4.5 billion yuan. The partnership will focus on investing in unlisted high-quality companies in the artificial intelligence and semiconductor sectors, aligning with China's policy direction of achieving technological self-reliance and industrial self-control. The fund targets companies with core technical barriers, broad domestic substitution potential, and strong long-term growth certainty. The announcement was made via a stock exchange filing and reported by Zhitong Finance.
Read sourceChina Life Insurance to Invest Up to 4.5 Billion Yuan in AI and Semiconductor Fund
China Life Insurance Company (601628.SH) announced on September 24 that it plans to participate as a limited partner in establishing the Qingdao Chengxin Zhida Equity Investment Center (Limited Partnership). The total capital commitments from all partners will not exceed 6 billion yuan, with China Life committing up to 4.5 billion yuan. The partnership will focus on investing in high-quality unlisted equity in the artificial intelligence and semiconductor sectors. The move reflects the company's strategic allocation into emerging technology fields.
Read sourceChina Life Plans Up to 4.5 Billion Yuan Investment in AI and Semiconductor Equity Fund
China Life Insurance Company (601628.SH) announced on September 24 that it will join with Wuxi China Life Chengda Equity Investment Center and other investors to establish the Qingdao Chengxin Zhida Equity Investment Center partnership. The partnership's total proposed capital contribution is up to 6 billion yuan, with China Life contributing up to 4.5 billion yuan as a limited partner. The fund will focus on investing in high-quality unlisted equity in artificial intelligence and semiconductor sectors. The general partner is China Life Chengda (Shanghai) Health Medical Equity Investment Management Co., Ltd. The announcement was reported by East Money via China Central Radio and Finance.
Read sourceChina Life Plans Up to 4.5 Billion Yuan Investment in AI and Semiconductor Fund
China Life Insurance Company (601628) announced on September 24 that it plans to invest up to 4.5 billion yuan in a new partnership focused on unlisted equity in the artificial intelligence and semiconductor sectors. The company, along with Wuxi China Life Chengda Equity Investment Center and other investors, will act as limited partners in the partnership, named Qingdao Chengxin Zhida Equity Investment Center. The general partner will be China Life Chengda (Shanghai) Health Medical Equity Investment Management Co., Ltd. The total proposed capital commitment for the partnership is up to 6 billion yuan, with China Life contributing up to 4.5 billion yuan. The partnership will primarily invest in high-quality unlisted equity in the AI and semiconductor sectors, as reported by People's Financial News.
Read source